Home | Business News | Browse by Publication | P | PR Newswire

FDA Agrees to Clinical Development Plans for ISA247; TSX:ISA.

Publication: PR Newswire
Publication Date: 25-FEB-04
Format: Online
Delivery: Immediate Online Access

Article Excerpt
Isotechnika Inc. today announced that the Food and Drug Administration (FDA) of the United States of America during a recent teleconference call has agreed to the proposed dose range finding study for trans-ISA247 in humans.

The single ascending dose study involving approximately 46 subjects will be completed over a six week period by MDS Pharma Services in Phoenix, Arizona. Dosing is scheduled to commence on March 9th, 2004. This study will be used as the foundation to determine dosing of trans-ISA247 in future clinical trials for both psoriasis and renal transplantation. "Based on analysis of previously collected data, trans-ISA247 is more bioavailable and...



More articles from PR Newswire
Suncor Energy Foundation donates record $5.3 million to 300 charitable..., February 25, 2004
Valmont Board Declares Quarterly Dividend., February 25, 2004
IPSCO Comments on Rating Agency's Actions., February 25, 2004
Motorola Launches IMS Interoperability Program for Hardware and Softwa..., February 25, 2004
Engineered Support to Present on March 3, 2004 at the Bear Stearns 11t..., February 25, 2004

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.